Svas Biosana, an Italy-based medical devices company, has raised €6m ($8m) from IMI Fondi Chiusi and from Banca Intesa’s Atlante Private Equity.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?